Research location
Sumter
South Carolina, United States
Advertisement
Research activity in Sumter
South Carolina, United StatesCureCurrent currently publishes aggregate city-level research activity for this location: 43 trials and 43 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Sumter
43 linked trials · page 1 of 1The LEADS Trial (Linking Exericise for Advancing Daily Stress Management)NCT07176234 · 2025-01-25 · 1 site observation
ENROLLING_BY_INVITATION
Sleep Signal Analysis for Current Major Depressive Episode (SAMDE)NCT05708222 · 2022-09-01 · 1 site observation
COMPLETED
Palbociclib in Real World PracticeNCT03280303 · 2017-01-04 · 1 site observation
COMPLETED
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial FibrillationNCT02942407 · 2016-12-01 · 1 site observation
COMPLETED
Observational Registry of Acthar Gel for Participants With Multiple Sclerosis RelapseNCT02633033 · 2015-11-24 · 1 site observation
COMPLETED
Evaluation of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Participants With Diabetic NephropathyNCT02065791 · 2014-02-17 · 1 site observation
COMPLETED
The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and OAD TherapyNCT01676116 · 2012-08-29 · 1 site observation
COMPLETED
A Study to Test Safety and Efficacy of Baricitinib in Participants With Diabetic Kidney DiseaseNCT01683409 · 2012-08-01 · 1 site observation
COMPLETED
A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)NCT01621178 · 2012-07-01 · 1 site observation
COMPLETED
CAROLINA: Cardiovascular Outcome Study of Linagliptin Versus Glimepiride in Patients With Type 2 DiabetesNCT01243424 · 2010-11-11 · 1 site observation
COMPLETED
A Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast CancerNCT01156753 · 2010-07-01 · 1 site observation
COMPLETED
Study Evaluating Neratinib Plus Paclitaxel VS Trastuzumab Plus Paclitaxel In ErbB-2 Positive Advanced Breast CancerNCT00915018 · 2009-08-21 · 1 site observation
COMPLETED
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving ChemotherapyNCT00858364 · 2009-07-17 · 1 site observation
TERMINATED
Study Evaluating The Effects Of Neratinib After Adjuvant Trastuzumab In Women With Early Stage Breast CancerNCT00878709 · 2009-07-09 · 1 site observation
COMPLETED
Phase 2b Study of Cetuximab With Platinum-Based Chemo as First Line Treatment of Recurrent or Advanced NSCLCNCT00828841 · 2008-12-01 · 1 site observation
COMPLETED
Safety and Tolerability of Vildagliptin Versus Sitagliptin in Patients With Type 2 Diabetes and Severe Renal Insufficiency (28-week Extension Study)NCT00770081 · 2008-09-01 · 1 site observation
COMPLETED
Carboplatin And Paclitaxel With Or Without CP-751, 871 (An IGF-1R Inhibitor) For Advanced NSCLC Of Squamous, Large Cell And Adenosquamous Carcinoma HistologyNCT00596830 · 2008-04-01 · 1 site observation
TERMINATED
Randomized Study Evaluating Ixabepilone Plus Capecitabine or Docetaxel Plus Capecitabine in Metastatic Breast CancerNCT00546364 · 2008-02-01 · 1 site observation
TERMINATED
Phase II Study for Previously Untreated Subjects With Non Small Cell Lung Cancer (NSCLC) or Small Cell Lung Cancer (SCLC)NCT00527735 · 2008-02-01 · 1 site observation
COMPLETED
Study of Ruxolitinib (INCB018424) Administered Orally to Patients With Androgen Independent Metastatic Prostate CancerNCT00638378 · 2008-02-01 · 1 site observation
TERMINATED
Safety and Tolerability of Vildagliptin Versus Sitagliptin in Patients With Type 2 Diabetes and Severe Renal InsufficiencyNCT00616811 · 2008-01-01 · 1 site observation
COMPLETED
Lapatinib In Combination With Chemotherapy In Subjects With Relapsed Breast CancerNCT00479856 · 2007-11-01 · 1 site observation
TERMINATED
GSK1572932A Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients With Non-Small Cell Lung CancerNCT00480025 · 2007-10-04 · 1 site observation
TERMINATED
Effect of Liraglutide or Exenatide Added to an Ongoing Treatment on Blood Glucose Control in Subjects With Type 2 DiabetesNCT00518882 · 2007-08-01 · 1 site observation
COMPLETED
Positive Action for Today's HealthNCT01025726 · 2007-07-01 · 1 site observation
COMPLETED
A Study Testing the Effectiveness of Nesiritide in Patients With Acute Decompensated Heart FailureNCT00475852 · 2007-05-01 · 1 site observation
COMPLETED
The Protégé Study - Clinical Trial of MGA031 in Children and Adults With Recent-Onset Type 1 Diabetes MellitusNCT00385697 · 2006-10-01 · 1 site observation
COMPLETED
The COREG And Lisinopril Combination Therapy In Hypertensive Subjects (COSMOS) TrialNCT00347360 · 2006-07-01 · 1 site observation
COMPLETED
Continued Efficacy and Safety of Zoledronic Acid (q 4 Wks vs. q 12 Wks) in the 2nd Year of Treatment in Patients With Bone Metastases From Breast CancerNCT00320710 · 2006-02-01 · 1 site observation
COMPLETED
An Observational Study Evaluating SYMLIN® (Pramlintide Acetate) Injection Use in Insulin Using Patients With Type 2 and Type 1 DiabetesNCT00229658 · 2005-09-01 · 1 site observation
COMPLETED
XeNA Study - A Study of Xeloda (Capecitabine) in Patients With Invasive Breast CancerNCT00127933 · 2005-08-01 · 1 site observation
COMPLETED
A Study of Xeloda (Capecitabine) in Women With HER2-Negative Metastatic Breast CancerNCT00121836 · 2005-06-01 · 1 site observation
COMPLETED
IMPROVE HF: Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient SettingNCT00303979 · 2005-05-01 · 1 site observation
COMPLETED
Study of Taxane/Carboplatin +/- Cetuximab as First-Line Treatment for Patients With Advanced/Metastatic Non-Small Cell Lung CancerNCT00112294 · 2004-12-01 · 1 site observation
COMPLETED
A Study to Evaluate Tarceva in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)NCT00091663 · 2004-08-01 · 1 site observation
COMPLETED
Non-small Cell Lung Cancer Study US75 (Z-PACT)NCT00086268 · 2004-04-01 · 1 site observation
COMPLETED
MEDI-522 in the Treatment of Patients With Metastatic Androgen-Independent Prostate CancerNCT00072930 · 2003-12-01 · 1 site observation
COMPLETED
Clinical Utility and Safety of Pramlintide in Subjects With Type 1 and Type 2 Diabetes MellitusNCT00108004 · 2003-04-01 · 1 site observation
COMPLETED
Demonstrate Exubera Works As Well As Avandia When Added To Sulfonylurea + Metformin In Controlling GlucoseNCT00150410 · 2003-01-01 · 1 site observation
COMPLETED
Polyglutamate Paclitaxel Plus Carboplatin Compared With Paclitaxel Plus Carboplatin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung CancerNCT00054210 · 2003-01-01 · 1 site observation
TERMINATED
Polyglutamate Paclitaxel Compared With Docetaxel in Treating Patients With Progressive Non-Small Cell Lung CancerNCT00054184 · 2003-01-01 · 1 site observation
TERMINATED
Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung CancerNCT00050960 · 2002-05-01 · 1 site observation
COMPLETED
Combination Chemotherapy With or Without Colony-stimulating Factors in Treating Women With Breast CancerNCT00014222 · 2000-12-04 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.